Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rubella Immunisation”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)UnknownNCT04638985
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Who this might be right for
Vaccine
China National Biotec Group Company Limited 600
Not applicableStudy completedNCT00962819
What this trial is testing

Measles, Mumps, and Rubella (MMR) Immunity in College Students

Who this might be right for
MeaslesMumpsRubella
Sri Edupuganti, MD MPH 74
Not applicableUnknownNCT00932269
What this trial is testing

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Who this might be right for
DiphtheriaTetanusPertussis+6 more
Swedish Institute for Infectious Disease Control 5,400
Not applicableStudy completedNCT00013871
What this trial is testing

Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs

Who this might be right for
HIV InfectionsHepatitis BMeasles+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT01544764
What this trial is testing

Examining Adolescent Assessment, Feedback, Incentive, and Exchange (AFIX) in North Carolina

Who this might be right for
Adolescent Health ServicesImmunization
University of North Carolina, Chapel Hill 91
Testing effectiveness (Phase 2)Study completedNCT04394689
What this trial is testing

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Who this might be right for
MeaslesRubellaVaccination+1 more
Micron Biomedical, Inc 281
Not applicableLooking for participantsNCT05923970
What this trial is testing

Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta?

Who this might be right for
Vaccination FailureVaccine Response Impaired
University of Alberta 200
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Post-approval studies (Phase 4)Study completedNCT00731965
What this trial is testing

Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis

Who this might be right for
Arthritis, Juvenile Rheumatoid
N.M. Wulffraat 140
Post-approval studies (Phase 4)Study completedNCT01847872
What this trial is testing

IPV Clinical Trial - The Gambia

Who this might be right for
Poliomyelitis
London School of Hygiene and Tropical Medicine 1,504
Large-scale testing (Phase 3)Study completedNCT00871117
What this trial is testing

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 478
Not applicableUnknownNCT05154097
What this trial is testing

Immunity Duration Study Eight Years After Vaccination of Children 12 to 23 Months With the Triple Viral Vaccine (Measles, Mumps and Rubella)

Who this might be right for
Measles Vaccine
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 190
Post-approval studies (Phase 4)UnknownNCT05279248
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Measles+2 more
Zhejiang Provincial Center for Disease Control and Prevention 300
Not applicableStudy completedNCT02151773
What this trial is testing

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination

Who this might be right for
Measles/Rubella
Takeda 3,493
Not applicableStudy completedNCT01369394
What this trial is testing

Making Decisions About the Measles-Mumps-Rubella Vaccine

Who this might be right for
MeaslesMumpsRubella+1 more
University of Michigan 79
Not applicableStudy completedNCT02934295
What this trial is testing

Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies

Who this might be right for
Pregnancy
Hopital Foch 192
Post-approval studies (Phase 4)Study completedNCT02325310
What this trial is testing

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR

Who this might be right for
MeaslesRubellaMumps
Assistance Publique - Hôpitaux de Paris 14
Not applicableStudy completedNCT04646239
What this trial is testing

Biomarkers of Trained Immunity Following MMR Vaccination

Who this might be right for
Covid19
Washington University School of Medicine 96
Not applicableStudy completedNCT02158364
What this trial is testing

Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination

Who this might be right for
Measles/Rubella
Takeda 3,331
Testing effectiveness (Phase 2)Study completedNCT00861744
What this trial is testing

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Who this might be right for
RubellaMumpsMeasles+1 more
GlaxoSmithKline 1,259
Load More Results